News, Announcements and Expert Commentary from Inova

Posts Tagged ‘ITMI’

FDA Approves Cutting-Edge Cancer Drug from Inova Schar Cancer Institute Clinical Trial

dart board with a red dart in the center bulls eye

Inova’s Dr. John Deeken served as the site principal investigator for this prestigious study In groundbreaking news for the medical and cancer research community, the Food and Drug Administration (FDA) approved a new, breakthrough cancer drug, larotrectinib, or Vitrakvi®, that targets specific genetic mutations in adult and pediatric patients. This is only the second tissue-agnostic…

Read More

Prenatal Genetic Tests and Care for High-Risk Obstetric Patients (Video with Dr. Sarah Poggi)

In this video, Inova’s Dr. Sarah Poggi provides information about advances in prenatal testing. This lecture includes information about prenatal single gene deletion carrier testing; non-invasive prenatal testing (NIPT) using cell-free DNA; and microarray analysis. Dr. Poggi is a maternal-fetal medicine specialist at the Brock Family Antenatal Testing Center at Inova Alexandria Hospital in Northern…

Read More

NPR Visits Inova to Document Infant-Health Research Study

nurse swabbing a newborn baby

Inova’s vaginal seeding study featured on NPR’s Morning Edition NPR’s Morning Edition has profiled the groundbreaking vaginal seeding study at Inova Women’s Hospital that aims to discover if babies born by C-section will benefit from a swab of their mother’s microbes. The article explains how vaginal seeding “was developed in response to the sharp rise…

Read More

Improving the Infant Microbiome: New Inova Study Leads the Way

Suchitra K. Hourigan, MD, is board-certified in pediatrics and pediatric gastroenterology. She sees patients at Pediatric Specialists of Virginia, a medical collaboration between Inova and Children’s National. Newborn babies inherit a lot from their mothers — including beneficial bacteria that can influence their health for years to come. The human body is home to trillions…

Read More

For babies born by Caesarean section, can a simple swab reduce rates of obesity, asthma and allergies?

newborn grasping adult finger

Inova clinical trial investigates outcomes of exposing newborns to mother’s microbes While Caesarean section (CS) delivery can be lifesaving for both new mothers and their babies, children born by CS have an approximately 50 percent increased risk of childhood obesity, along with asthma and allergies. There is a marked difference between the microbiomes, the community…

Read More

Genetic testing & counseling helped guide this breast cancer patient’s journey

Family Matters Genetic testing and counseling help guide a Northern Virginia wife and mother’s decisions about her breast cancer treatment When Nicole Sharabi, 42, tested positive last year for stage 3, triple-negative breast cancer, she was ready to take action. But before beginning any medical treatment, Nicole underwent genetic testing. “I wanted as much information…

Read More

Inova MediMap Team Wins 2018 Greater Washington Innovation Award

On April 4, 2018, the Northern Virginia Chamber of Commerce presented Inova with a 2018 Greater Washington Innovation Award for MediMap Baby, a pharmacogenomics test that helps provide guidance to physicians in prescribing safer and more effective medications based on an individual’s DNA. The annual awards ceremony celebrates thought leadership, innovation and creativity demonstrated by…

Read More

Considering New Direct-to-Consumer Breast Cancer Tests? First, Get the Facts

Tiffani A. DeMarco, MS, LCGC, is a licensed and certified genetic counselor and the manager of the cancer genetic counseling program at the Inova Translational Medicine Institute. She and her team of cancer genetic counselors specialize in counseling patients and family members at risk for hereditary cancers. The U.S. Food and Drug Administration (FDA) recently gave…

Read More

Immunotherapy: Cancer Care Gets Customized

Timothy L. Cannon, MD, is board certified in medical oncology and hematology, and has a special interest in managing gastrointestinal cancers. Dr. Cannon is the clinical director and moderator of Inova’s weekly molecular tumor board, which matches patients with targeted therapies based on molecular diagnostics.      Tiffani A. DeMarco, MS, CGC, is a board-certified…

Read More

Inova Partners with Veritas Genetics to Offer Whole Genome Sequencing and Interpretation

inova logo

MyMap™ will provide genomic information to help guide health, diet and lifestyle decisions Falls Church, VA (September 28, 2017) —  Inova announced today it has partnered with Veritas Genetics to provide whole genome sequencing and interpretation services. MyMap includes myGenome by Veritas and MediMap® pharmacogenomic testing by Inova; it also integrates Inova’s genetic counseling, research and…

Read More